首页 ChromaDex(usCDXC)-基本信息

ChromaDex(usCDXC)-基本信息

日报更新时间:

周报更新时间:01-23 11:54

行情信息

今开价:

最高价:

成交量:

昨收价:

最低价:

最新价:

行情图标
概要信息

英文名称:ChromaDex


简介:Chromadex Corporation是天然产品行业的研发和质量控制产品与服务的领先供应商


电话:1-949-4190288


最新量化综合结论
百科信息
  • 相关网站
  • 百科
  • 员工交易记录
  • 持股信息
  • 领导人信息

ChromaDex Corporation是一家膳食补充剂和食品配料公司,2011年,达特茅斯学院宣布授予ChromaDex全球独家烟酰胺核苷制造工艺的权利,该工艺以Tru Niagen品牌销售和销售。ChromaDex公司还提供合同研究服务,用于采购原材料,识别新化合物,以及开发大规模制造工艺。ChromaDex获得密西西比大学和美国农业部的许可专利,用于商业开发紫檀芪,并通过该公司的BluScience产品线销售商标为pTeroPure的化合物(ChromaDex目前已经不再销售PteroPure)。ChromaDex Corporation提供烟酰胺核苷(NIAGEN),一种新型维生素B3,用于增强用于健康老化的烟酰胺腺嘌呤二核苷酸(NAD)水平; 和Immulina,一种螺旋藻提取物和化合物,用于改善人体免疫功能。ChromaDex Corporation还提供参考标准和精细化学品,以对膳食补充剂,化妆品,食品和饮料以及制药行业的原材料和成品进行质量控制。ChromaDex Corporation还提供一系列咨询服务,包括监管支持,产品开发,风险管理和诉讼支持。ChromaDex Corporation在美国和加拿大市场直销和销售其产品; 并通过国际经销商销售。

交易日期 交易人 职位 类型 交易份额 价格
2017-08-14 Fried (Robert N) President Buy 10000 3.15
2017-05-23 Champion River Ventures, Ltd. Beneficial Owner of More than 10% Class Buy 3782288 2.60
2017-05-23 Pioneer Step Holdings, Ltd. Beneficial Owner of More than 10% Class Buy 2521526 2.60
2017-05-18 Allen Stephen R Director Buy 3000 3.20
2017-03-19 Allen Stephen R Director Buy 2000 2.81
2017-03-11 Fried (Robert N) President Buy 166667 --
2017-03-11 Fried (Robert N) President Buy 339595 2.72
2016-12-11 Jaksch (Frank Louis Jr) Chief Executive Officer Buy 2000 2.42
2016-08-31 Jaksch (Frank Louis Jr) Chief Executive Officer Buy 1500 3.32
2016-08-31 Fried (Robert N) Director Buy 15000 3.39
2016-06-19 Rhonemus (Troy Allen) Chief Operating Officer Buy 2800 2.89
2016-06-19 Rhonemus (Troy Allen) Chief Operating Officer Buy 5000 3.80
2016-01-28 Fried (Robert N) Director Sell 5063 1.26

机构持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Invesco Capital Management LLC 81207 0.15% -1825 -2.20% 2019-07-31
State Street Corporation 559202 1.01% 4060 0.73% 2019-03-31
Northern Trust Investments Inc 722659 1.30% 22278 3.18% 2019-07-31
Vanguard Investments Australia Ltd 1166417 2.11% -- -- 2019-07-31
Tieton Capital Management, LLC 1257890 2.27% 165425 15.14% 2019-03-31
BlackRock Fund Advisors 1297637 2.34% 1574 0.12% 2019-07-31
ICONIQ Capital, LLC 1707317 3.08% -- -- 2019-03-31
Vanguard Group Inc 1760133 3.17% 165618 10.39% 2019-03-31
BlackRock Inc 1940528 3.50% 26610 1.39% 2019-03-31
Northern Trust Corp 413821 0.75% 2385 0.58% 2019-03-31
Northern Trust Investments N A 413821 0.75% 2385 0.58% 2019-03-31
Geode Capital Management, LLC 379635 0.68% -313811 -45.25% 2019-03-31
Charles Schwab Investment Management Inc 84490 0.15% 12690 17.67% 2019-03-31
BlackRock Institutional Trust Company NA 148510 0.27% 1189 0.81% 2019-07-31
Granite Investment Partners, LLC 167689 0.30% 78373 87.75% 2019-03-31
BlackRock 184719 0.33% -5055 -2.66% 2019-07-31
UBS Group AG 194950 0.35% 42607 27.97% 2019-03-31
First Republic Inv Mgmt Inc 268221 0.48% -- -- 2019-03-31
State Street Global Advisors 338300 0.61% 21600 6.82% 2019-07-31
Fidelity Management & Research Company 363630 0.66% 15421 4.43% 2019-07-31
BlackRock Asset Management Canada Ltd 817373 1.47% -678 -0.08% 2019-05-31
BNY Mellon Investment Management 116869 0.21% 24348 26.32% 2018-12-31
Bank of New York Mellon Corp 128810 0.23% 24408 23.38% 2018-12-31
Morgan Stanley - Brokerage Accounts 87443 0.16% 3148 3.73% 2018-12-31
AXA Equitable Funds Management Group, LLC 83537 0.15% -- -- 2019-02-28
Oppenheimer & Co Inc 92500 0.17% -- -- 2018-09-30
TIAA-CREF Investment Management LLC 98448 0.18% 39422 66.79% 2018-09-30
Teachers Advisors LLC 101744 0.18% 50872 100.00% 2018-09-30
UBS Securities LLC 145704 0.26% 24292 20.01% 2018-06-30
Millennium Management LLC 504525 0.92% -38469 -7.08% 2018-03-31
Goldman Sachs Group Inc 229405 0.42% 214439 1432.84% 2018-03-31
Goldman, Sachs & Co. 229405 0.42% 214439 1432.84% 2018-03-31
BlueCrest Capital Management Ltd. 124510 0.23% 124510 -- 2018-03-31
Wells Fargo & Co 117536 0.21% 64287 120.73% 2018-06-30
Arete Wealth Advisors, LLC 61592 0.11% 2333 3.94% 2018-06-30
LAURION CAPITAL MANAGEMENT LP 70667 0.13% 70667 -- 2018-03-31
Wells Fargo Advisors, LLC 80100 0.15% 50100 167.00% 2018-06-30
Morgan Stanley & Co Inc 87906 0.16% -10718 -10.87% 2018-06-30
Northern Trust Asset Management 92756 0.17% -495 -0.53% 2018-07-31
North Star Investment Management Corp 108334 0.20% -45000 -29.35% 2018-03-31
State Street Corp 530652 0.97% 506392 2087.35% 2018-06-30
PIONEER STEP HOLDINGS Ltd 4333960 8.06% 487805 12.68% 2017-11-17
CHAMPION RIVER VENTURES Ltd. 6500937 12.08% 731707 12.68% 2017-11-17
Invesco PowerShares Capital Mgmt LLC 172102 0.31% 172102 -- 2018-03-31
BlackRock Advisors (UK) Ltd 56700 0.10% -44287 -43.85% 2018-03-31
Bt Alex Brown Inc 56482 0.10% 56482 -- 2018-03-31
Citadel Advisors Llc 59340 0.11% 59340 -- 2018-03-31
Susquehanna Financial Group, LLLP 218039 0.40% 193241 779.26% 2018-03-31
Teachers Advisors Inc 109898 0.20% 109898 -- 2018-06-30
Trexquant Investment LP 43748 0.08% 43748 -- 2017-12-31
Susquehanna International Group, LLP 218039 0.40% 193241 779.26% 2018-03-31
Precept Management LLC 200000 0.37% 200000 -- 2017-12-31
J.P. Morgan Securities Inc 40109 0.07% 21471 115.20% 2017-12-31
Thompson Davis & Co Inc 25350 0.05% -4400 -14.79% 2017-12-31
Davidson D A & Co 44000 0.08% 1000 2.33% 2017-12-31
Cetera Advisor Networks LLC 25000 0.05% 25000 -- 2017-12-31
Renaissance Technologies Corp 45100 0.08% 45100 -- 2017-12-31
Virtu Financial LLC 63189 0.13% 63189 -- 2017-09-30
Segall Bryant & Hamill 25000 0.05% -5000 -16.67% 2017-12-31
Jacob Asset Management Of New York LLC 25000 0.05% -- -- 2017-12-31
Squarepoint Ops LLC 30000 0.06% 6639 28.42% 2017-09-30
Element Capital Management LLC 32351 0.07% -103950 -76.27% 2017-09-30
Pekin Singer Strauss Asset Mgmt Inc 35000 0.07% 35000 -- 2017-09-30
Sunrise Partners LLC 106250 0.23% 106250 -- 2017-06-30
Credit Suisse First Boston (CSFB) 55381 0.12% 55381 -- 2017-06-30
Silver Capital Management, LLC 143015 0.38% 44035 44.49% 2016-09-30
Rhumbline Advisers 39401 0.10% 6500 19.76% 2016-09-30
FMG LLC 62176 0.16% -- -- 2016-11-30
California State Teachers Retirement Sys 59720 0.16% -300 -0.50% 2016-09-30
BlackRock Advisors LLC 110729 0.29% -1268 -1.13% 2016-09-30
Spark Investment Management LLC 135900 0.36% 26500 24.22% 2016-09-30
共同基金持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
BlackRock Extended Equity Market 58457 0.11% -80 -0.14% 2019-06-30
NT R2000 Index Fund - NL 147978 0.27% 5954 4.19% 2019-06-30
State Street Russell Small Cap 157600 0.28% -- -- 2019-07-31
NT R2000 Growth Index Fund - Non-Lending 162098 0.29% -- -- 2019-06-30
State Street Russell Small/Mid Cap 163600 0.30% 21600 15.21% 2019-07-31
iShares Russell 2000 Growth ETF 357503 0.65% -- -- 2019-07-30
Vanguard Extended Market Index Fund 362727 0.65% -- -- 2019-06-30
iShares Russell 2000 ETF 805905 1.46% 1573 0.20% 2019-07-30
Vanguard Total Stock Market Index Fund 1166417 2.11% -- -- 2019-06-30
Fidelity 123820 0.22% -- -- 2019-06-30
NT R2000 Growth Index Fund - Lending 115295 0.21% 1800 1.59% 2019-06-30
BlackRock Russell 2500 62883 0.11% 118 0.19% 2019-06-30
The Vanguard - Russell 2000 Grwth Idx CF 68862 0.12% -- -- 2019-06-30
Russell 2000 Index Non-Lendable Fund E 75055 0.14% -528 -0.70% 2019-06-30
Adara Smaller Companies Fund 78373 0.14% -- -- 2019-06-30
Schwab Small Cap Index Fund 78680 0.14% -- -- 2019-06-30
Invesco S&P SmallCap Momentum ETF 81207 0.15% -- -- 2019-06-23
iShares Micro-Cap ETF 99335 0.18% -- -- 2019-07-30
Northern Trust Russell 2000 Index DC NL 112340 0.20% 4151 3.84% 2019-06-30
Invesco Russell 2000 Pure Growth ETF 81207 0.15% -- -- 2019-06-23
iShares US Small Cap ETF (CAD-Hedged) 769154 1.39% -1287 -0.17% 2019-05-30
AXA 2000 Managed Volatility Portfolio 57391 0.10% -- -- 2019-01-31
BlackRock Russell 2000 55402 0.10% 911 1.67% 2019-03-31
TIAA-CREF Small-Cap Blend 46955 0.09% -- -- 2018-12-31
Vanguard Instl Total Stock Market Idx Fd 46038 0.08% -- -- 2019-01-31
Vanguard Russell 2000 Index Fund 45769 0.08% -696 -1.50% 2019-01-31
LVIP SSgA Small Cap Index Fund 44900 0.08% -- -- 2019-01-31
iShares Russell 2000 Small-Cap Index Fd 44059 0.08% -- -- 2019-01-31
Jacob Micro Cap Growth Fund 30000 0.05% -- -- 2018-12-31
Vanguard Balanced Index Fund 28600 0.05% -- -- 2019-01-31
Master Small Cap Index Series 44059 0.08% -- -- 2019-01-31
iShares Russell 3000 ETF 28706 0.05% -96 -0.33% 2019-01-31
Invesco DWA SmallCap Momentum ETF 172102 0.31% -- -- 2018-03-31
iShares Micro-Cap 102177 0.17% -- -- 2018-09-12
Jacob Micro Cap Growth Institutional 35000 0.06% 10000 40.00% 2018-06-30
LVIP SSgA Small Cap Index Std 44900 0.08% 44900 -- 2018-06-30
Vanguard Russell 2000 ETF 43176 0.08% 812 1.92% 2018-07-31
TIAA-CREF Small-Cap Blend Idx Inst 46955 0.09% -- -- 2018-07-31
Vanguard Total Stock Mkt Idx 1003499 1.83% 78246 8.46% 2018-07-31
iShares Russell 2000 Growth 381061 0.62% -367 -0.10% 2018-09-12
Vanguard Extended Market Idx Inv 328726 0.60% -- -- 2018-07-31
Northern Trust Russell 2000 Index Fund - DC - Non-Lending 92756 0.17% -495 -0.53% 2018-07-31
Schwab Small Cap Index 71800 0.13% -- -- 2018-07-31
The Vanguard Russell 2000 Growth Index 68136 0.12% -- -- 2018-07-31
PowerShares Russell 2000 Pure Growth ETF 70709 0.11% -- -- 2018-09-13
CREF Stock R1 59026 0.11% -- -- 2018-07-31
AXA 2000 Managed Volatility K 57391 0.10% -- -- 2018-07-31
Fidelity Spartan 56591 0.10% -- -- 2018-07-31
Vanguard Instl Ttl Stk Mkt Idx InstlPls 54307 0.10% -- -- 2018-07-31
iShares Russell 3000 25130 0.05% -24 -0.10% 2018-08-09
Vanguard Balanced Index Inv 28600 0.05% -- -- 2018-06-30
Master Small Cap Index 27899 0.05% 27899 -- 2018-06-30
Vanguard Russell 2000 Growth ETF 27635 0.05% 27635 -- 2018-06-30
BNY Mellon EB DL Small Cap SIF 26693 0.05% 26693 -- 2018-06-30
BNY Mellon EB DL Mkt Completion 22180 0.04% -- -- 2018-03-31
BNY Mellon Market Completion Fund UC1 7139 0.01% 5400 310.52% 2018-03-31
iShares Core S&P Total US Stock Mkt 8951 0.02% 4 0.04% 2018-07-05
SPDR 13588 0.03% 36 0.27% 2018-07-05
The Vanguard Total Stock Market Index 5500 0.01% -- -- 2018-05-31
TFS Small Cap 5672 0.01% 5672 -- 2017-07-31
PowerShares Russell 2000 Equal Wt ETF 6231 0.01% -- -- 2018-07-02
AXA/Lord Abbett Micro Cap K 6869 0.01% -- -- 2018-04-30
Wells Fargo Dow Jones Target 2040 A 1349 -- -83 -5.80% 2018-04-30
Wells Fargo Dow Jones Target 2030 A 1274 -- -74 -5.49% 2018-04-30
Bridgeway Small-Cap Momentum N 650 -- 650 -- 2017-12-31
Wells Fargo Dow Jones Target 2050 R6 833 -- 31 3.87% 2018-02-28
PowerShares DWA SmallCap Momentum ETF 172102 0.24% 25812 17.64% 2018-03-29
Meeder Spectrum 252 -- -- -- 2017-12-31
Nuveen Small Cap Index I 1420 -- -217 -13.26% 2017-03-31
Vantagepoint Mid/Small Company Index I 5063 0.01% -- -- 2016-09-30
GuideMark 18816 0.05% -- -- 2016-12-31
CREF Equity Index R1 21144 0.06% -- -- 2016-12-31

Steven D. Rubin Mr. Steven D. Rubin is an Independent Director at Red Violet, Inc., an Independent Non-Executive Director at Chromadex Corp., an Independent Director at Eloxx Pharmaceuticals, Inc., an Independent Director at Cocrystal Pharma, Inc., an Independent Director at Castle Brands, Inc., an Independent Director at Non-Invasive Monitoring Systems, Inc., a Chairman at Neovasc, Inc., a Chairman at B-Balloon Ltd., a Director & Executive Vice President-Administration at OPKO Health, Inc. and a Secretary & Vice President at The Frost Group LLC. He is on the Board of Directors at Red Violet, Inc., Chromadex Corp., BioReference Laboratories, Inc., Eloxx Pharmaceuticals, Inc., Cocrystal Pharma, Inc., Castle Brands, Inc., Non-Invasive Monitoring Systems, Inc., Kidville, Inc. and OPKO Health, Inc. Mr. Rubin was previously employed as an Independent Director by Sevion Therapeutics, Inc., a Chairman by SciVac Therapeutics, Inc., an Independent Director by VBI Vaccines, Inc., an Independent Director by Cogint, Inc., a Director, Chief Executive & Financial Officer by Tiger X Medical, Inc., an Independent Director by OPKO Biologics Ltd., a Secretary & Director by Ideation Acquisition Corp., an Executive Vice President-Administration by eXegenics, Inc., an Independent Director by Dreams, Inc., a Secretary, Senior Vice President & General Counsel by IVAX Corp., a Secretary, Senior Vice President & General Counsel by Telergy, Inc., and a Secretary & General Counsel by General Binding Corp. He also served on the board at Eloxx Pharmaceuticals Ltd., BioZone Pharmaceuticals, Inc., clickNsettle.com, Inc., Cocrystal Discovery, Inc., Longfoot Communications Corp., Cellular Technical Services Co., Inc., SafeStitch Medical, Inc., Stearns Weaver Miller Weissler Alhadeff & Sitterson PA, BioCardia, Inc., IDI, Inc. (United States) and TransEnterix, Inc. He received his undergraduate degree from Tulane University (Louisiana) and a graduate degree from the University of Florida.
Stephen A. Block Mr. Stephen A. Block is a Member-Executive Committee at Tech Coast Angels (Venture Capital). He is also a Co-Founder & Director at Masher Media, Inc., and a Managing Partner at Venture Farm LLC. He is on the Board of Directors at Allylix, Inc., Chromadex Corp., and Senomyx, Inc. Prior to joining Tech Coast Angels in March 2005, Mr. Block was President and Member Board of Governors with Flavor & Extract Manufacturers Association. He also was Senior Vice President, General Counsel and Secretary International Flavors & Fragrances Inc. Mr. Block holds a Juris Doctor degree from Harvard Law School and a Bachelor of Arts degree cum laude from Yale University, where he majored in Russian Studies.
Stephen A. Block Mr. Stephen A. Block is a Member-Executive Committee at Tech Coast Angels (Venture Capital). He is also a Co-Founder & Director at Masher Media, Inc., and a Managing Partner at Venture Farm LLC. He is on the Board of Directors at Allylix, Inc., Chromadex Corp., and Senomyx, Inc. Prior to joining Tech Coast Angels in March 2005, Mr. Block was President and Member Board of Governors with Flavor & Extract Manufacturers Association. He also was Senior Vice President, General Counsel and Secretary International Flavors & Fragrances Inc. Mr. Block holds a Juris Doctor degree from Harvard Law School and a Bachelor of Arts degree cum laude from Yale University, where he majored in Russian Studies.
Kevin M. Farr Presently, Kevin M. Farr is Chief Financial & Accounting Officer of Chromadex Corp. He is also on the board of Polaris Industries Inc. and Chairman at The Mattel Children's Foundation, Member of California Society of Certified Public Accountants and Member of The American Institute of Certified Public Accountants. In his past career he occupied the position of Chief Financial Officer & Executive Vice President at Mattel, Inc. Kevin M. Farr received an undergraduate degree from Michigan State University, an MBA from Kellogg School of Management and a graduate degree from Northwestern University.
Jeffrey R. Baxter Currently, Jeffrey R. Baxter holds the position of President, Chief Executive Officer & Director at VBI Vaccines, Inc. and President, Chief Executive Officer & Director at VBI Vaccines (Delaware), Inc. (a subsidiary of VBI Vaccines, Inc.). Mr. Baxter is also on the board of Chromadex Corp. In his past career he held the position of SVP-Finance, Operations, Research & Development at GlaxoSmithKline Plc, Managing Partner at The Column Group LLC, Principal at British American Tobacco plc, Principal at Unilever Plc and President, Chief Executive Officer & Director at Variation Biotechnologies (US), Inc.
Frank L. Jaksch Frank L. Jaksch founded Chromadex Corp. and ChromaDex, Inc. He occupies the position of Executive Chairman of Chromadex Corp. and President for Pagoda Pharmaceuticals Ltd. He is also Member of American Botanical Council, Member of American Herbal Products Association and Member of American Chemical Society. In the past he was President & Chief Executive Officer at ChromaDex, Inc. and Manager-International Subsidiaries at Phenomenex, Inc. He received an undergraduate degree from Valparaiso University.
Robert N. Fried Robert N. Fried is an entrepreneur and businessperson who founded 5 companies, among them: Fried Films, Spirit EMX LLC and Ideation Mobile Media LLC and who has been at the head of 8 different companies. Currently, he holds the position of President, CEO, COO & Director at Chromadex Corp., Chief Executive Officer at Feeln (which he founded) and President for Fried Films (which he founded in 2010). In his past career Mr. Fried was Chairman & Chief Executive Officer at WhatsHotNow.com, Inc., Independent Director at Fluent, Inc. and President & Chief Executive Officer at Ideation Acquisition Corp. (a subsidiary of Fluent, Inc.), President & Chief Executive Officer of Savoy Pictures, Inc., Chief Executive Officer at Spirit EMX LLC (he founded the company in 2007), Executive Vice President-Production at Columbia Pictures Industries, Inc. and Director-Business Development for Twentieth Century Fox Film Corp. Robert N. Fried received a graduate degree from Cornell University and an MBA from Columbia Business School.
Robert N. Fried Robert N. Fried is an entrepreneur and businessperson who founded 5 companies, among them: Fried Films, Spirit EMX LLC and Ideation Mobile Media LLC and who has been at the head of 8 different companies. Currently, he holds the position of President, CEO, COO & Director at Chromadex Corp., Chief Executive Officer at Feeln (which he founded) and President for Fried Films (which he founded in 2010). In his past career Mr. Fried was Chairman & Chief Executive Officer at WhatsHotNow.com, Inc., Independent Director at Fluent, Inc. and President & Chief Executive Officer at Ideation Acquisition Corp. (a subsidiary of Fluent, Inc.), President & Chief Executive Officer of Savoy Pictures, Inc., Chief Executive Officer at Spirit EMX LLC (he founded the company in 2007), Executive Vice President-Production at Columbia Pictures Industries, Inc. and Director-Business Development for Twentieth Century Fox Film Corp. Robert N. Fried received a graduate degree from Cornell University and an MBA from Columbia Business School.
Kurt A. Gustafson Kurt A. Gustafson is CFO, EVP & Chief Accounting Officer at Spectrum Pharmaceuticals, Inc. Mr. Gustafson is also on the board of Xencor, Inc. and Chromadex Corp. In his past career he was Chief Financial Officer & Vice President at Halozyme Therapeutics, Inc., Chief Financial Officer & VP-Manufacturing Finance at Amgen, Inc. Chief Financial Officer & Vice President-Finance of Amgen Europe BV and Chief Financial Officer for Amgen International AG (both are subsidiaries of Amgen, Inc.) and Staff Auditor at Horwath Velez & Co. PSC. He received an undergraduate degree from North Park University and an MBA from the University of California, Los Angeles.
Andrew Shao Dr. Andrew Shao is a Vice President-Scientific & Regulatory Affairs at Chromadex Corp., a Member at American Society for Nutrition, Inc., a Member at American Society For Quality, Inc. and a Member at Institute of Food Technologists, Inc. Dr. Shao was previously employed as a Vice President-Global Nutrition Policy by Herbalife Ltd., a Senior Scientist by General Nutrition Corp., and a Member by National Strength & Conditioning Association. He received his undergraduate degree from Brandeis University, a graduate degree from Tufts University and a doctorate degree from Tufts University.
Mark J. Friedman Presently, Mark J. Friedman holds the position of Secretary & General Counsel for Chromadex Corp. He is also on the board of Herbalife Family Foundation and Bet Tzedek Legal Services. Mr. Friedman previously occupied the position of Head-Investor Relations at Cannabis Science, Inc., Secretary & General Counsel of Pinkberry Ventures, Inc., Executive Vice President & General Counsel for Herbalife Nutrition Ltd., Senior Counsel & Associate Corporate Secretary at BP Plc and Senior Counsel & Associate Corporate Secretary at Atlantic Richfield Co., Inc. (a subsidiary of BP Plc), Secretary, Senior Vice President & General Counsel of American Golf Corp. and SVP-Business Development & General Counsel at Pinkberry, Inc. Mr. Friedman received a graduate degree from the University of Southern California and an undergraduate degree from the University of California, Davis.
Stephen A. Block Mr. Stephen A. Block is a Member-Executive Committee at Tech Coast Angels (Venture Capital). He is also a Co-Founder & Director at Masher Media, Inc., and a Managing Partner at Venture Farm LLC. He is on the Board of Directors at Allylix, Inc., Chromadex Corp., and Senomyx, Inc. Prior to joining Tech Coast Angels in March 2005, Mr. Block was President and Member Board of Governors with Flavor & Extract Manufacturers Association. He also was Senior Vice President, General Counsel and Secretary International Flavors & Fragrances Inc. Mr. Block holds a Juris Doctor degree from Harvard Law School and a Bachelor of Arts degree cum laude from Yale University, where he majored in Russian Studies.
Andrew Johnson Presently, Andrew Johnson occupies the position of Director-Investor Relations for Chromadex Corp.
Matthew Roberts Matthew Roberts is Chief Scientific Officer & Senior VP-Innovation at Chromadex Corp. In his past career Dr. Roberts occupied the position of Chief Technology & Quality Officer at Pharmavite LLC, Chief Scientific Officer of The Nature's Bounty Co. and Director-Strategic Business Unit at Nestl�0�1�0�8 Purina PetCare Co. He received an MBA from the University of Washington, a doctorate from Cornell University and an undergraduate degree from Purdue University.
Ben Shichman Presently, Ben Shichman holds the position of Chief Technical Officer for Chromadex Corp. In his past career he was Chief Technology & Operating Officer at iConstituent, Vice President-Technology of Guidance Solutions, Inc. and Executive Vice President of InvestCloud, Inc. He received an undergraduate degree from George Washington University.
Robert N. Fried Robert N. Fried is an entrepreneur and businessperson who founded 5 companies, among them: Fried Films, Spirit EMX LLC and Ideation Mobile Media LLC and who has been at the head of 8 different companies. Currently, he holds the position of President, CEO, COO & Director at Chromadex Corp., Chief Executive Officer at Feeln (which he founded) and President for Fried Films (which he founded in 2010). In his past career Mr. Fried was Chairman & Chief Executive Officer at WhatsHotNow.com, Inc., Independent Director at Fluent, Inc. and President & Chief Executive Officer at Ideation Acquisition Corp. (a subsidiary of Fluent, Inc.), President & Chief Executive Officer of Savoy Pictures, Inc., Chief Executive Officer at Spirit EMX LLC (he founded the company in 2007), Executive Vice President-Production at Columbia Pictures Industries, Inc. and Director-Business Development for Twentieth Century Fox Film Corp. Robert N. Fried received a graduate degree from Cornell University and an MBA from Columbia Business School.
Tsz Ho Lau Currently, Tsz Ho Lau holds the position of Co-Chairman of Celsius Holdings, Inc. Mr. Lau is also on the board of Chromadex Corp. and Champion River Ventures Ltd. Mr. Lau received an undergraduate degree from Peking University.
Wing Tak Yu Wing Tak Yu is on the board of Chromadex Corp. and Pioneer Step Holdings Ltd. She previously held the position of Chief Digital Officer of Horizons Digital Group Ltd. Ms. Yu received an undergraduate degree from the University of Toronto.
Mark J. Friedman Presently, Mark J. Friedman holds the position of Secretary & General Counsel for Chromadex Corp. He is also on the board of Herbalife Family Foundation and Bet Tzedek Legal Services. Mr. Friedman previously occupied the position of Head-Investor Relations at Cannabis Science, Inc., Secretary & General Counsel of Pinkberry Ventures, Inc., Executive Vice President & General Counsel for Herbalife Nutrition Ltd., Senior Counsel & Associate Corporate Secretary at BP Plc and Senior Counsel & Associate Corporate Secretary at Atlantic Richfield Co., Inc. (a subsidiary of BP Plc), Secretary, Senior Vice President & General Counsel of American Golf Corp. and SVP-Business Development & General Counsel at Pinkberry, Inc. Mr. Friedman received a graduate degree from the University of Southern California and an undergraduate degree from the University of California, Davis.
Lisa Bratkovich Currently, Lisa Bratkovich holds the position of Chief Executive Officer & Principal at Direct Upside Group LLC and Chief Marketing Officer for Chromadex Corp. Ms. Bratkovich is also on the board of Girls In Tech Los Angeles and Organization of Women Executives. In her past career she occupied the position of Senior Vice President-Marketing at Guthy-Renker LLC. She received an undergraduate degree from the University of California, Los Angeles.
Aron Erickson Aron Erickson holds the position of Technology Director at Chromadex Corp. He received an undergraduate degree from Saint John's University.
Jordan A. Gropack Presently, Jordan A. Gropack holds the position of Vice President-People at Chromadex Corp. In the past he was Senior Employment Counsel at Goldman, Magdalin & Krikes LLP, Counsel at Appell, Hilaire, Benardo LLP and Head-Human Resources at Spokeo, Inc. Mr. Gropack received a graduate degree from Southwestern Law School.
Brianna Gerber Brianna Gerber is Senior Director-Investor Relations at Chromadex Corp.
Alberto Bottene Mr. Alberto Bottene is a Senior VP-Sales & Business Development at Chromadex Corp. He received his undergraduate degree from Thunderbird School of Global Management.

量化对比

全部评论 0

  • 暂无评论

阿布量化公众号二维码 abu_quant 扫一扫关注阿布量化

热门推荐